The third factor is the natural predisposition of bureaucracies, both governmental and private, to exploit secrecy to whatever degree they are licensed to do so, and in this administration they're given virtually carte blanche.

One of the principal factors fueling the proliferation of the abuse of secrecy and sensitive but unclassifieds is the administration's adherence to the unitary executive principal. This administration more than any of its predecessors believes that it is its responsibility to collect power onto itself in the executive office when it comes to the conduct of war, foreign policy, the management of agencies and departments, regulations, etc.

I love the idea of a shield law; I don't know of any journalist who doesn't love the idea of a shield law. It's all in the details. Some of the shield laws that were floating around sounded good, but when you looked at them, exceptions or exclusions or broadness in the language really invited some problems.

If you are a reporter trying to find out what the hell's going on in government now, you have a devilish time. It is murder to set up an interview. It is murder to get someone's phone number. It's murder to be able to get in and talk to someone without a handler being present to chill it, or who doesn't insist upon questions in advance.

The mechanics vary from place to place and from office to office. The handling of SBUs can be different in the same agency just across the hall, one from another. There are virtually no standards.

There are benefits in the sense that there's still a certain level of confidence. But there are liabilities because you can coordinate and manipulate better as the instruments of oversight are more under your control. You don't have so many rogue operations.

A one year study by the Washington Post has documented 620 cases in which experimental drugs have been implicated in the deaths of cancer patients....And they amount to merely a fraction of the thousands of people who in recent years have died or suffered terribly from cancer experiments.